+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Adenosine Triphosphate (ATP) Assays Global Market Report 2024

  • PDF Icon

    Report

  • 200 Pages
  • January 2024
  • Region: Global
  • The Business Research Company
  • ID: 5866019
The adenosine triphosphate (atp) assays market has grown rapidly in recent years. It will grow from $1.77 billion in 2023 to $1.97 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%. The expansion observed in the historical period can be credited to progress in biomedical research, advancements in drug discovery and development, heightened adoption in clinical diagnostics, growing demands for environmental monitoring, and an increased emphasis on cell-based assays.

The adenosine triphosphate (atp) assays market is expected to see rapid growth in the next few years. It will grow to $3.01 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The anticipated expansion in the forecast period can be attributed to the sustained growth of the biopharmaceutical industry, the widening implementation of personalized medicine approaches, heightened focus on ensuring food and beverage safety, technological innovations in assay platforms, and the increasing application in industrial processes. Major forecasted trends encompass advancements in ATP detection technologies, a growing demand for high-throughput screening, integration into clinical diagnostics, an emphasis on food and beverage safety testing, and expanded application in sports and performance monitoring.

The anticipated rise in the occurrence of cancer, chronic ailments, and infectious diseases is poised to drive the expansion of the adenosine triphosphate (ATP) assay market in the future. Cancer, characterized by unregulated cell growth, chronic conditions with prolonged persistence, and infectious diseases caused by pathogenic microorganisms, collectively contribute to the demand for ATP assays. These assays serve as crucial diagnostic tools, assessing cellular viability, detecting microbial contamination, monitoring treatment effectiveness, and evaluating metabolic and mitochondrial dysfunction. As an example, data from the World Health Organization in October 2022 indicated that approximately 10.6 million individuals were affected by tuberculosis (TB) in 2021, with 1.6 million fatalities recorded, including 187,000 HIV-positive individuals. Additionally, the International Diabetes Federation reported in 2021 that around 537 million adults were living with diabetes, a number projected to escalate to 783 million by 2045. Thus, the increasing prevalence of cancer, chronic ailments, and infectious diseases acts as a driving force behind the adenosine triphosphate (ATP) assay market.

The growing demand for personalized treatment approaches is expected to fuel the expansion of the adenosine triphosphate (ATP) assays market. Personalized treatments involve utilizing knowledge about an individual's unique genetic or protein makeup to prevent, detect, or treat diseases effectively. In the context of infectious disease management, ATP assays play a crucial role by assessing the efficacy of antimicrobial agents against specific pathogens, aiding in the selection of personalized treatment strategies. For instance, the US Food and Drug Administration (FDA) approved 12 personalized medicines in 2022, constituting around 34% of all newly approved therapeutic molecular entities, as reported by the Personalized Medicine Coalition. This surge in demand for personalized medicine underscores its pivotal role in driving the growth of the adenosine triphosphate (ATP) assays market.

The evolution of novel assays stands out as a prominent trend gaining momentum within the adenosine triphosphate (ATP) assay market. Key companies operating in this domain are introducing groundbreaking products, such as the SensiLux kit by BC Aplicaciones, a biotechnology firm based in Spain. The SensiLux kit is a unique testing solution designed for detecting microbial ATP in samples, utilizing bioluminescence for detection following sample pre-incubation. Its applications extend to areas such as food safety and contamination testing. Additionally, this offering includes ATP kits featuring advanced multi-injector automatic luminometers, proprietary control software, and future-oriented robot-based sample automation, providing customers with tailored solutions. BC Aplicaciones' programming and computer systems department have developed unique software to manage robot and luminometer operations.

Major players in the ATP assay market are directing their focus towards innovative solutions such as the AccuPoint Advanced Next Generation (NG) to bolster their market presence. This comprehensive sanitation monitoring system is engineered to validate and confirm the efficacy of sanitation programs by identifying organic residues lingering on surfaces and in liquids post-cleaning. For instance, in May 2021, Neogen Corporation, a US-based food safety entity, introduced the AccuPoint Advanced NG system, comprising a handheld instrument, innovative samplers, and data manager software. This system functions by measuring adenosine triphosphate (ATP), rendering the invisible visible and furnishing a reliable, consistent, and documented dataset on sanitation effectiveness. Offering automated data reporting, trend tracking, and audit functionalities, the AccuPoint Advanced NG system is designed to enhance sanitation testing across diverse sectors such as food safety, healthcare, and environmental monitoring.

In October 2021, Abcam plc, a UK-based biotechnology enterprise, completed the acquisition of BioVision Inc for $340 million. This strategic acquisition aimed to augment Abcam's capabilities, expanding its cellular assay portfolio in critical domains such as oncology, immuno-oncology, neuroscience, and epigenetics. The acquisition of BioVision, a US-based manufacturer specializing in ATP assays and test kits, empowered Abcam to gain a competitive edge and scale up its operations significantly within the market.

Major companies operating in the adenosine triphosphate (atp) assays market report are Merck KGaA, Thermo Fisher Scientific Inc., PerkinElmer Inc., Lonza Group, Promega Corporation, Agilent Technologies Inc., Abcam plc, Danaher Corporation, 3M Co., Geno Technology Inc., NEOGEN Corporation, Biomerieux SA, AAT Bioquest Inc., MBL International Corporation, Charm Sciences Inc., Cell Signaling Technology Inc., Cayman Chemical Company, Vazyme Biotech Co. Ltd., SignalChem Lifesciences Corporation, Kaneka Corporation, Novus Biologicals LLC, NANOGEN Biotechnologies Inc., Nacalai Tesque Inc., MoBiTec GmbH, Lumigen Inc., Jena Bioscience GmbH, Goryo Chemical Inc., Cosmo Bio Co. Ltd., BPS Bioscience Inc., BioTek Instruments Inc.

North America was the largest region in the adenosine triphosphate (ATP) assays market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adenosine triphosphate (atp) assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the adenosine triphosphate (atp) assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary types of ATP assays include luminometric ATP assays, enzymatic ATP assays, bioluminescence resonance energy transfer (BRET) ATP assays, cell-based ATP assays, among others. Luminometric ATP assays, specifically, leverage bioluminescence principles to measure ATP levels in samples. They are widely used in research, drug discovery, and biomedical applications for assessing cellular energy status, measuring enzymatic activity, evaluating cell viability, and screening ATP-modulating compounds. These assays consist of essential components such as consumables, accessories, and instruments utilized across diverse fields including drug discovery and development, clinical diagnostics, environmental testing, and food safety and quality assessment. Their applications extend to various end-users such as pharmaceutical and biotechnology companies, the food and beverage industry, hospitals, diagnostics laboratories, as well as academic and research institutions.

The adenosine triphosphate (ATP) assays market research report provides adenosine triphosphate (ATP) assays market statistics, including adenosine triphosphate (ATP) assays industry global market size, regional shares, competitors with an adenosine triphosphate (ATP) assays market share, detailed adenosine triphosphate (ATP) assays market segments, market trends and opportunities, and any further data you may need to thrive in the adenosine triphosphate (ATP) assays industry. This adenosine triphosphate (ATP) assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The adenosine triphosphate (ATP) assays market consists of revenues earned by entities by providing testing services related to colorimetric and fluorescent assays. The market value includes the value of related goods sold by the service provider or included within the service offering. The adenosine triphosphate (ATP) assays market also includes sales of luminometer, and chemiluminescent which are used in adenosine triphosphate (ATP) assay services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Adenosine Triphosphate (ATP) Assays Market Characteristics3. Adenosine Triphosphate (ATP) Assays Market Trends and Strategies
4. Adenosine Triphosphate (ATP) Assays Market - Macro Economic Scenario
4.1. Impact of High Inflation on the Market
4.2. Ukraine-Russia War Impact on the Market
4.3. COVID-19 Impact on the Market
5. Global Adenosine Triphosphate (ATP) Assays Market Size and Growth
5.1. Global Adenosine Triphosphate (ATP) Assays Market Drivers and Restraints
5.1.1. Drivers of the Market
5.1.2. Restraints of the Market
5.2. Global Adenosine Triphosphate (ATP) Assays Historic Market Size and Growth, 2018-2023, Value ($ Billion)
5.3. Global Adenosine Triphosphate (ATP) Assays Forecast Market Size and Growth, 2023-2028, 2033F, Value ($ Billion)
6. Adenosine Triphosphate (ATP) Assays Market Segmentation
6.1. Global Adenosine Triphosphate (ATP) Assays Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Luminometric ATP (Adenosine Triphosphate) Assays
  • Enzymatic ATP (Adenosine Triphosphate) Assays
  • Bioluminescence Resonance Energy Transfer (BRET) ATP (Adenosine Triphosphate) Assays
  • Cell-Based ATP (Adenosine Triphosphate) Assays
  • Other Types
6.2. Global Adenosine Triphosphate (ATP) Assays Market, Segmentation by Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Consumables and Accessories
  • Instruments
6.3. Global Adenosine Triphosphate (ATP) Assays Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Drug Discovery and Development
  • Clinical Diagnostics
  • Environmental Testing
  • Food Safety and Quality Testing
  • Other Applications
6.4. Global Adenosine Triphosphate (ATP) Assays Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical and Biotechnology Companies
  • Food and Beverage Industry
  • Hospitals and Diagnostics Laboratories
  • Academic and Research Institutions
7. Adenosine Triphosphate (ATP) Assays Market Regional and Country Analysis
7.1. Global Adenosine Triphosphate (ATP) Assays Market, Split by Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Adenosine Triphosphate (ATP) Assays Market, Split by Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Adenosine Triphosphate (ATP) Assays Market
8.1. Asia-Pacific Adenosine Triphosphate (ATP) Assays Market Overview
  • Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Adenosine Triphosphate (ATP) Assays Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Adenosine Triphosphate (ATP) Assays Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Adenosine Triphosphate (ATP) Assays Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Adenosine Triphosphate (ATP) Assays Market
9.1. China Adenosine Triphosphate (ATP) Assays Market Overview
9.2. China Adenosine Triphosphate (ATP) Assays Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Adenosine Triphosphate (ATP) Assays Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Adenosine Triphosphate (ATP) Assays Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Adenosine Triphosphate (ATP) Assays Market
10.1. India Adenosine Triphosphate (ATP) Assays Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Adenosine Triphosphate (ATP) Assays Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Adenosine Triphosphate (ATP) Assays Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Adenosine Triphosphate (ATP) Assays Market
11.1. Japan Adenosine Triphosphate (ATP) Assays Market Overview
11.2. Japan Adenosine Triphosphate (ATP) Assays Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Adenosine Triphosphate (ATP) Assays Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Adenosine Triphosphate (ATP) Assays Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Adenosine Triphosphate (ATP) Assays Market
12.1. Australia Adenosine Triphosphate (ATP) Assays Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Adenosine Triphosphate (ATP) Assays Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Adenosine Triphosphate (ATP) Assays Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Adenosine Triphosphate (ATP) Assays Market
13.1. Indonesia Adenosine Triphosphate (ATP) Assays Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Adenosine Triphosphate (ATP) Assays Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Adenosine Triphosphate (ATP) Assays Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Adenosine Triphosphate (ATP) Assays Market
14.1. South Korea Adenosine Triphosphate (ATP) Assays Market Overview
14.2. South Korea Adenosine Triphosphate (ATP) Assays Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Adenosine Triphosphate (ATP) Assays Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Adenosine Triphosphate (ATP) Assays Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Adenosine Triphosphate (ATP) Assays Market
15.1. Western Europe Adenosine Triphosphate (ATP) Assays Market Overview
15.2. Western Europe Adenosine Triphosphate (ATP) Assays Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Adenosine Triphosphate (ATP) Assays Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Adenosine Triphosphate (ATP) Assays Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Adenosine Triphosphate (ATP) Assays Market
16.1. UK Adenosine Triphosphate (ATP) Assays Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Adenosine Triphosphate (ATP) Assays Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Adenosine Triphosphate (ATP) Assays Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Adenosine Triphosphate (ATP) Assays Market
17.1. Germany Adenosine Triphosphate (ATP) Assays Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Adenosine Triphosphate (ATP) Assays Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Adenosine Triphosphate (ATP) Assays Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Adenosine Triphosphate (ATP) Assays Market
18.1. France Adenosine Triphosphate (ATP) Assays Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Adenosine Triphosphate (ATP) Assays Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Adenosine Triphosphate (ATP) Assays Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Adenosine Triphosphate (ATP) Assays Market
19.1. Italy Adenosine Triphosphate (ATP) Assays Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Adenosine Triphosphate (ATP) Assays Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Adenosine Triphosphate (ATP) Assays Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Adenosine Triphosphate (ATP) Assays Market
20.1. Spain Adenosine Triphosphate (ATP) Assays Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Adenosine Triphosphate (ATP) Assays Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Adenosine Triphosphate (ATP) Assays Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Adenosine Triphosphate (ATP) Assays Market
21.1. Eastern Europe Adenosine Triphosphate (ATP) Assays Market Overview
21.2. Eastern Europe Adenosine Triphosphate (ATP) Assays Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Adenosine Triphosphate (ATP) Assays Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Adenosine Triphosphate (ATP) Assays Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Adenosine Triphosphate (ATP) Assays Market
22.1. Russia Adenosine Triphosphate (ATP) Assays Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Adenosine Triphosphate (ATP) Assays Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Adenosine Triphosphate (ATP) Assays Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Adenosine Triphosphate (ATP) Assays Market
23.1. North America Adenosine Triphosphate (ATP) Assays Market Overview
23.2. North America Adenosine Triphosphate (ATP) Assays Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Adenosine Triphosphate (ATP) Assays Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Adenosine Triphosphate (ATP) Assays Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Adenosine Triphosphate (ATP) Assays Market
24.1. USA Adenosine Triphosphate (ATP) Assays Market Overview
24.2. USA Adenosine Triphosphate (ATP) Assays Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Adenosine Triphosphate (ATP) Assays Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Adenosine Triphosphate (ATP) Assays Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Adenosine Triphosphate (ATP) Assays Market
25.1. Canada Adenosine Triphosphate (ATP) Assays Market Overview
25.2. Canada Adenosine Triphosphate (ATP) Assays Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Adenosine Triphosphate (ATP) Assays Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Adenosine Triphosphate (ATP) Assays Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Adenosine Triphosphate (ATP) Assays Market
26.1. South America Adenosine Triphosphate (ATP) Assays Market Overview
26.2. South America Adenosine Triphosphate (ATP) Assays Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Adenosine Triphosphate (ATP) Assays Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Adenosine Triphosphate (ATP) Assays Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Adenosine Triphosphate (ATP) Assays Market
27.1. Brazil Adenosine Triphosphate (ATP) Assays Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Adenosine Triphosphate (ATP) Assays Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Adenosine Triphosphate (ATP) Assays Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Adenosine Triphosphate (ATP) Assays Market
28.1. Middle East Adenosine Triphosphate (ATP) Assays Market Overview
28.2. Middle East Adenosine Triphosphate (ATP) Assays Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Adenosine Triphosphate (ATP) Assays Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Adenosine Triphosphate (ATP) Assays Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Adenosine Triphosphate (ATP) Assays Market
29.1. Africa Adenosine Triphosphate (ATP) Assays Market Overview
29.2. Africa Adenosine Triphosphate (ATP) Assays Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Adenosine Triphosphate (ATP) Assays Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Adenosine Triphosphate (ATP) Assays Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Adenosine Triphosphate (ATP) Assays Market Competitive Landscape and Company Profiles
30.1. Adenosine Triphosphate (ATP) Assays Market Competitive Landscape
30.2. Adenosine Triphosphate (ATP) Assays Market Company Profiles
30.2.1. Merck KGaA
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Thermo Fisher Scientific Inc.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. PerkinElmer Inc.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Lonza Group
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Promega Corporation
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Global Adenosine Triphosphate (ATP) Assays Market Competitive Benchmarking32. Global Adenosine Triphosphate (ATP) Assays Market Competitive Dashboard33. Key Mergers and Acquisitions in the Adenosine Triphosphate (ATP) Assays Market
34. Adenosine Triphosphate (ATP) Assays Market Future Outlook and Potential Analysis
34.1 Adenosine Triphosphate (ATP) Assays Market in 2028 - Countries Offering Most New Opportunities
34.2 Adenosine Triphosphate (ATP) Assays Market in 2028 - Segments Offering Most New Opportunities
34.3 Adenosine Triphosphate (ATP) Assays Market in 2028 - Growth Strategies
34.3.1 Market Trend-based Strategies
34.3.2 Competitor Strategies
35. Appendix
35.1. Abbreviations
35.2. Currencies
35.3. Historic and Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Analyst
35.6. Copyright and Disclaimer

Executive Summary

This report provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on adenosine triphosphate (apt) assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia-Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for adenosine triphosphate (apt) assays? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Luminometric ATP (Adenosine Triphosphate) Assays; Enzymatic ATP (Adenosine Triphosphate) Assays; Bioluminescence Resonance Energy Transfer (BRET) ATP (Adenosine Triphosphate) Assays; Cell-Based ATP (Adenosine Triphosphate) Assays; Other Types

2) By Component: Consumables And Accessories; Instruments
3) By Application: Drug Discovery And Development; Clinical Diagnostics; Environmental Testing; Food Safety And Quality Testing; Other Applications
4) By End User: Pharmaceutical And Biotechnology Companies; Food and Beverage Industry; Hospitals And Diagnostics Laboratories; Academic And Research Institutions

Key Companies Mentioned: Merck KGaA; Thermo Fisher Scientific Inc.; PerkinElmer Inc.; Lonza Group; Promega Corporation

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes

Delivery Format: PDF, Word and Excel Data Dashboard

Companies Mentioned

  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • PerkinElmer Inc.
  • Lonza Group
  • Promega Corporation
  • Agilent Technologies Inc.
  • Abcam plc
  • Danaher Corporation
  • 3M Co.
  • Geno Technology Inc.
  • NEOGEN Corporation
  • Biomerieux SA
  • AAT Bioquest Inc.
  • MBL International Corporation
  • Charm Sciences Inc.
  • Cell Signaling Technology Inc.
  • Cayman Chemical Company
  • Vazyme Biotech Co. Ltd.
  • SignalChem Lifesciences Corporation
  • Kaneka Corporation
  • Novus Biologicals LLC
  • NANOGEN Biotechnologies Inc.
  • Nacalai Tesque Inc.
  • MoBiTec GmbH
  • Lumigen Inc.
  • Jena Bioscience GmbH
  • Goryo Chemical Inc.
  • Cosmo Bio Co. Ltd.
  • BPS Bioscience Inc.
  • BioTek Instruments Inc.

Methodology

Loading
LOADING...